SHANNAN BRYANT: Open Payments
NPI 1225635477 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 12 payments from 6 companies in 2025. Trend: 2023 $60 · 2024 $305 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Calliditas Therapeutics US Inc. | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Travere Therapeutics, Inc. | 1 | $21 |
Products named: Fabhalta, JYNARQUE, TARPEYO, BENLYSTA, ACTHAR, Vanrafia.
Industry payments across CO — which companies pay providers there.
